Surpass, Inc. Receives CRO Leadership Awards
3/14/2014 12:59:02 PM
March 13, 2014 OSCEOLA, WI and MOUNTAIN VIEW, CA —— Surpass, Inc. (“Surpass”), a recognized leader in preclinical research, announced that it has received CRO Leadership Awards in the following categories: Quality, Innovation, Reliability, Productivity, and Regulatory. The awards are given by Life Science Leader Magazine based on industry research conducted by Nice Insight which includes feedback from customers that use the CRO Services. “At Life Science Leader, we think having data-driven awards is more objective and valuable than having those awarded as a result of a nomination and voting process. The winners should be proud of these awards because they were determined by data gathered from customers,” - Rob Wright, Editor in Chief, Life Science Leader. Additional Information can be found in the March 2014 edition of Life Science Leader Magazine (page 19).
“Surpass is grateful to our clients for these CRO Leadership Awards which recognize our dedicated, experienced team as true innovation partners delivering translational scientific data that advances novel medical therapies into the marketplace,” said Dr. Tim Pelura, President and CEO. “Surpass outperformed all our direct competitors winning awards in five out of five major categories, with recognition in 13 of the 20 subcategories that were assessed – a true testament to Surpass’ commitment to excellence in the preclinical space.”
Companies are recognized that achieve top 20th percentile perception scores in areas of Innovation, Productivity, Quality, Regulatory, and Reliability. Each category is further divided into Emerging Pharma, Big Pharma, Biotech and Emerging Biotech. Surpass' Awards can be viewed on the CRO Leadership Awards website with the full list of winners found at http://www.lifescienceleader.com/resource/cro-leadership-awards.
A recognized leader in preclinical research, Surpass provides comprehensive services for the development, characterization, and evaluation of medical devices, pharmaceuticals, biologics, and combination products with extensive expertise in surgical and interventional procedures. Experienced professionals, state-of-the-art facilities with advanced equipment, and proven methods make Surpass a trusted partner and lab of choice for preclinical feasibility, product development, pivotal GLP safety, and physician training studies.
Surpass has a breadth of case experience in preclinical studies including feasibility and safety assessments of ablation systems, vascular grafts, orthopedic prostheses, stents, closure devices, valves, infusion pumps, drug coated balloons, neurostimulators, pharmaceuticals, imaging systems, cardiac assist devices, and more. Whether you are a startup or an established player, Surpass is uniquely qualified to make your study successful. Contact Surpass today at (651) 433-4277 (Midwest/Twin Cities Area) or (650) 477-8267 (Silicon Valley).
Visit www.surpassinc.com for more information. Connect with Surpass, Inc. on LinkedIn.
Help employers find you! Check out all the jobs and post your resume.
comments powered by